Dublin experts working to diagnose stroke quickly
India Medtronic Private Limited, a wholly owned subsidiary of Dublin-headquartered Medtronic plc (NYSE:MDT), has formed a partnership with Mumbai’s Qure.ai to integrate artificial intelligence (AI) for advanced stroke management in India.
The partnership combines Medtronic’s leadership in neurosciences with Qure’s AI enabled innovations.
The collaboration aims to provide AI solutions to comprehensive stroke centers as well as primary stroke centers and establish a hub-and-spoke network which is connected via technology.
“Medtronic is working toward a future where stroke can be diagnosed quickly and treated efficiently to potentially save a patient’s life. Introducing AI will personalize healthcare technology — in real time,” said Michael Blackwell, Vice President & Managing Director, Medtronic India.
“We are thrilled to collaborate with Qure.ai to support surgeons in diagnosing and treating stroke by enabling quicker decision-making, streamlining data sharing between two hospitals and in improving efficiencies so that more stroke patients in India can be treated within the critical time window,” Blackwell said on 4 Apr 2023.
Qure.ai CEO & Co-Founder Prashant Warier elaborated, “Partnering with Medtronic India, we will integrate Qure.ai’s AI-powered neuro-critical solutions suite to detect & manage stroke more effectively.
“Our cutting-edge technology utilizes advanced algorithms to analyze medical images, so that healthcare providers can make informed decisions with improved diagnostic accuracy and speed.
“Our collaboration will also enhance operational efficiency in hospitals, optimizing hub-spoke pathways. The partnership with Medtronic is another important pillar in our commitment to utilize the power of AI to enhance patient care and bring equitable healthcare to all,” he said.
The two-company network will aid in faster identification, decision making and triaging of stroke patients, thus potentially facilitating better patient outcomes. fiinews.com
